Last reviewed · How we verify
NCT06056453: IPAP
Interpersonal Psychotherapy in Adolescents With Polycystic Ovary Syndrome
NA trial testing Interpersonal Psychotherapy in Interpersonal Psychotherapy in 30 participants. Completed in 14 July 2023.
14 July 2023
Quick facts
| Lead sponsor | University of Colorado, Denver |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 20 September 2021 |
| Primary completion | 14 July 2023 |
| Estimated completion | 14 July 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Interpersonal Psychotherapy
Conditions studied
- Interpersonal Psychotherapy — all drugs for Interpersonal Psychotherapy →
- Polycystic Ovary Syndrome — all drugs for Polycystic Ovary Syndrome →
Sponsor
University of Colorado, Denver
Who can join
Adults 12 to 17, female only, with Interpersonal Psychotherapy or Polycystic Ovary Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main purpose of this study is to find out whether taking part in a group-based interpersonal psychotherapy (IPT) program designed to improve mood and lessen stress in girls with PCOS will improve depression, unhealthy eating behaviors, weight, and insulin resistance.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06056453
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Interpersonal Psychotherapy
Trials testing the same drug.
- NCT06014671 — The Effect of Interpersonal Psychotherapy on Quality of Life Among People Living With HIVAIDS · NA · completed
- NCT04973930 — Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer · Phase 3 · suspended
- NCT03466346 — SMART-DAPPER: Leveraging the Depression And Primary-care Partnership for Effectiveness-implementation Research Project · NA · completed
- NCT03594773 — Modeling Multi-level Dyadic Behavior to Transform the Science and Practice of Psychotherapy Process and Outcome. · NA · completed
- NCT03170908 — Effective Implementation of Interpersonal Psychotherapy · terminated
Other University of Colorado, Denver trials
Trials by the same sponsor.
- NCT07292285 — The Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial. · not yet recruiting
- NCT07021937 — Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity · Phase 3 · not yet recruiting
- NCT07453732 — Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients. · NA · not yet recruiting
- NCT07038278 — 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma · EARLY_PHASE1 · not yet recruiting
- NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06056453 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Colorado, Denver
- Last refreshed: 28 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06056453.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing